Recurrence-free survival in patients with melanoma treated with pembrolizumab are reported.
Combining either oleclumab or monalizumab with durvalumab provided a progression-free survival benefit over durvalumab alone.
Researchers sought to determine whether cumulative lifetime excess weight was associated with risk for colon cancer.
A novel life expectancy calculator could allow for more personalized management of men with prostate cancer.
Quality of life outcomes were reported favorably for trials that showed no improvement in quality of life.
A team of investigators examined the potential of fecal and salivary microbiota to serve as diagnostic biomarkers for pancreatic ductal adenocarcinoma.
Researchers observed a 61% reduction in the risk of invasive cancer among patients who completed a home exercise program and took vitamin D3 and omega-3 fatty acids daily.
Researchers sought to determine the palliative effects of chocolate consumption in older people with cancer.
In 2 minutes, the portable ATUSA system automatically scans the entire breast volume and provides 3D visualization of the breast tissue.
Direct inhibition of STAT3 signaling by TTI-101 is expected to lead to reduced tumor growth.
Three biomarkers were associated with prognosis after COVID-19 treatment.
This weekly series highlights eponyms in oncology. This week, we explore the history and namesake of HeLa cells.
Researchers investigated how young adult cancer survivors felt about using medical crowdfunding to help cover their healthcare and basic living costs.
Rates of surveillance mammography were stable from 2004 to 2009 but declined 1.5% annually from 2009 to 2016.
Researchers found no increased risk of any brain tumors among cell phone users.
Although mortality-to-incidence indices are improving globally, the increasing burden of AML is “concerning,” according to researchers.
Researchers sought to determine whether not undergoing a colonoscopy after a positive FIT was linked to increased incidence of colorectal cancer and mortality.
Children prescribed a medication containing a phthalate had a 19% higher risk of developing any childhood cancer.
Patients living in warmer climates were more likely to achieve a pathologic complete response and had a lower risk of death.
Data suggest the overall incidence of melanoma in the United States is stabilizing after nearly a century of continuous increase.